Along with advanced medicines, precision medicine is the next big thing. Globally there is a big demand, and in the UK, it has been highlighted as an area of focus for the Industrial Strategy with an extra £210m of funding announced as part of the 2017 white paper. Precision medicine aims to treat patients based upon their individual characteristics including genomics, environmental and lifestyle data. It has the potential to have major impacts on patient outcomes and reduce the costs associated with ineffective treatments. However, there are still challenges with this approach, including increasing complexity and volume of data available and reimbursement issues.
This event will look at drivers for precision medicine from discovery through to development of new therapies and how building collaborative relationship could be key for overcoming the barriers and driving innovation.